The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
Open accessAbstract
Although activity that induced tumor regression was observed and termed tumor necrosis factor (TNF) as early as the 1960s, the true identity of TNF was not clear until 1984, when Aggarwal and coworkers reported, for the first time, the isolation of 2 cytotoxic factors: one, derived from macrophages (molecular mass 17 kDa), was named TNF, and the second, derived from lymphocytes (20 kDa), was named lymphotoxin. Because the 2 cytotoxic factors exhibited 50% amino acid sequence homology and bound to the same receptor, they came to be called TNF-α and TNF-β. Identification of the protein sequences led to cloning of their cDNA. Based on sequence homology to TNF-α, now a total of 19 members of the TNF superfamily have been identified, along with 29 interacting receptors, and several molecules that interact with the cytoplasmic domain of these receptors. The roles of the TNF superfamily in inflammation, apoptosis, proliferation, invasion, angiogenesis, metastasis, and morphogenesis have been documented. Their roles in immunologic, cardiovascular, neurologic, pulmonary, and metabolic diseases are becoming apparent. TNF superfamily members are active targets for drug development, as indicated by the recent approval and expanding market of TNF blockers used to treat rheumatoid arthritis, psoriasis, Crohns disease, and osteoporosis, with a total market of more than US $20 billion. As we learn more about this family, more therapeutics will probably emerge. In this review, we summarize the initial discovery of TNF-α, and the insights gained regarding the roles of this molecule and its related family members in normal physiology and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“death receptors, whose activation depends on the binding of the cognate ligand(s)”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [269]
In the citing paper
“Extrinsic apoptosis is mostly driven by either of two types of plasma membrane receptors: (1) death receptors, whose activation depends on the binding of the cognate ligand(s), and (2) dependence receptors, whose activation occurs when the levels of their specific ligand drop below a specific threshold [267 269–271].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [269]
In the citing paper
“dependence receptors, whose activation occurs when the levels of their specific ligand drop below a specific threshold [267 269–271].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [269]
In the citing paper
“Death receptors include (but are not limited to): Fas cell surface death receptor (FAS; also known as CD95 or APO-1), and TNF receptor superfamily member 1A (TNFRSF1A; best known as TNFR1), 10a (TNFRSF10A; best known as TRAILR1 or DR4), and 10b (TNFRSF10B; best known as TRAILR2 or DR5) [269, 270, 272, 273].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [269]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
RetractedMolecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Self-citationElevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,024
Hsu, H., Shu, H., Pan, M., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998
Tumour necrosis factor and cancer
Balkwill, F. R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2628 · Cited by 1,976
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
Kuida, K., Zheng, T. S., Na, S., Kuan, C.-Y., Yang, D., Karasuyama, H., RAKIC, P. T., & Flavell, R. A. (1996) · Nature · doi:10.1038/384368a0 · Cited by 1,881
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,732
Self-citationAggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,586
Self-citationSugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., & Shepard, H. M. (1985) · Science · doi:10.1126/science.3933111 · Cited by 1,572
Self-citationGeneralized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,526
Aviña-Zubieta, J. A., Choi, H. K., Sadatsafavi, M., Etminan, M., Esdaile, J. M., & Lacaille, D. V. (2008) · Arthritis Care & Research · doi:10.1002/art.24092 · Cited by 1,461
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
Rieux-Laucat, F., Deist, F. L., Hivroz, C., Roberts, I., Debatin, K., Fischer, A., & de Villartay, J. (1995) · Science · doi:10.1126/science.7539157 · Cited by 1,405
McDermott, M., Aksentijevich, I. A., Galon, J., McDermott, E. M., Ogunkolade, B.-W., Centola, M. B., Mansfield, E. A., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,404
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,399
Self-citationVarfolomeev, E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J., Mett, I., Rebrikov, D., Brodianski, V. M., Kemper, O., Kollet, O., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80609-3 · Cited by 1,332
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Self-citationDifferential Requirement for Caspase 9 in Apoptotic Pathways In Vivo
Hakem, R., Hakem, A., Duncan, G. S., Henderson, J. T., Woo, M., Soengas, M. S., Elia, A., de la Pompa, J. L., Kägi, D., Khoo, W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81477-4 · Cited by 1,296
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingPreprint
Lomaga, M. A., Yeh, W., Sarosi, I., Duncan, G. S., Furlonger, C. L., Ho, A. P., Morony, S., Capparelli, C., Van, G. Y., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,265
Rothe, J., Lesslauer, W., Loetscher, H., Lang, Y., Koebel, P., Köntgen, F., Althage, A., Zinkernagel, R. M., Steinmetz, M., & Bluethmann, H. (1993) · Nature · doi:10.1038/364798a0 · Cited by 1,246
Pasparakis, M., Alexopoulou, L., Episkopou, V., & Kollias, G. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y., Yoshida, R., Elia, A., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J. C., Ulevitch, R. J., & Cerami, A. (1985) · Nature · doi:10.1038/316552a0 · Cited by 1,132
A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., & Leder, P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80535-x · Cited by 1,102
An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway
Schiemann, B. J., Gommerman, J. L., Vora, K. A., Cachero, T. G., Shulga‐Morskaya, S., Dobles, M., Frew, E. M., & Scott, M. L. (2001) · Science · doi:10.1126/science.1061964 · Cited by 1,070
Lee, K., Li, E., Huber, L. J., Landis, S. C., Sharpe, A. H., Chao, M. V., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90286-l · Cited by 949
Li, Z., Chu, W., Hu, Y., Delhase, M., Deerinck, T. J., Ellisman, M. H., Johnson, R. S., & Karin, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1839 · Cited by 927
TNF-α in promotion and progression of cancer
Balkwill, F. R. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9005-3 · Cited by 919
Human tumor necrosis factor. Production, purification, and characterization.
Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89560-6 · Cited by 917
Self-citationFADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis
Yeh, W., de la Pompa, J. L., McCurrach, M. E., Shu, H., Elia, A., Shahinian, A., Ng, M. S. W., Wakeham, A. C., Khoo, W., Mitchell, K., et al. (1998) · Science · doi:10.1126/science.279.5358.1954 · Cited by 890
Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
Aggarwal, B. B., Eessalu, T. E., & Hass, P. E. (1985) · Nature · doi:10.1038/318665a0 · Cited by 876
Self-citationMice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome
Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H. M., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Distèche, C. M., Simoneaux, D. K., et al. (1993) · Science · doi:10.1126/science.7679801 · Cited by 829
Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase
Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T. J., Ellisman, M. H., Johnson, R. S., & Karin, M. (1999) · Science · doi:10.1126/science.284.5412.316 · Cited by 822
Characterization of tumor necrosis factor-deficient mice
Marino, M. W., Dunn, A. R., Grail, D., Inglese, M., Noguchi, Y., Richards, E. A., Jungbluth, A., Wada, H., Moore, M. A. S., Williamson, B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8093 · Cited by 767
Singer, G. G., & Abbas, A. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90067-1 · Cited by 689
Multitargeting by curcumin as revealed by molecular interaction studies
Gupta, S. C., Prasad, S., Kim, J. H., Patchva, S., Webb, L. J., Priyadarsini, K. I., & Aggarwal, B. B. (2011) · Natural Product Reports · doi:10.1039/c1np00051a · Cited by 683
Self-citationMutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans
Salzer, U., Chapel, H. M., WEBSTER, A. D. B., Pan‐Hammarström, Q., Schmitt-Graeff, A. H., Schlesier, M., Peter, H. H., Rockstroh, J., Schneider, P., Schäffer, A. A., et al. (2005) · Nature Genetics · doi:10.1038/ng1600 · Cited by 671
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity
Gray, P. W., Aggarwal, B. B., Benton, C. V., Bringman, T. S., Henzel, W. J., Jarrett, J. A., Leung, D. W., Moffat, B., Ng, P., Svedersky, L. P., et al. (1984) · Nature · doi:10.1038/312721a0 · Cited by 643
Self-citationTACI-Ig Neutralizes Molecules Critical for B Cell Development and Autoimmune Disease
Gross, J. A., Dillon, S. R., Mudri, S., Johnston, J. V., Littau, A., Roque, R., Rixon, M. W., Schou, O., Foley, K. P., Haugen, H. S., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00183-2 · Cited by 625
Schreiber, S., Rutgeerts, P. J., Fedorak, R. N., Khaliq–Kareemi, M., Kamm, M. A., Boivin, M., Bernstein, C. N., Staun, M., Thomsen, O. Ø., & Innes, A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.064 · Cited by 578
Regulation of proliferation, survival and apoptosis by members of the TNF superfamily
Gaur, U., & Aggarwal, B. B. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00490-8 · Cited by 556
Self-citationSong, H. Y., Régnier, C. H., Kirschning, C. J., Goeddel, D. V., & Rothe, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9792 · Cited by 554
The role of tumor necrosis factor in the pathophysiology of heart failure
Feldman, A. M., Combes, A., Wagner, D., Kadakomi, T., Kubota, T., Li, Y. Y., & McTiernan, C. F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00600-2 · Cited by 502
Stephens, G. L., McHugh, R. S., Whitters, M. J., Young, D. A., Luxenberg, D. P., Carreno, B. M., Collins, M. A., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5008 · Cited by 499
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., Macpherson, H. K., Wallace, R. G. H., Hul, W. V., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 484
TNF: A master switch for inflammation to cancer
Sethi, G. (2008) · Frontiers in Bioscience · doi:10.2741/3066 · Cited by 458
Banks, T. A., Rouse, B. T., Kerley, M. K., Blair, P. J., Godfrey, V., Kuklin, N. A., Bouley, D. M., Thomas, J., Kanangat, S., & Mucenski, M. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.1685 · Cited by 440
Kapadia, S. R., Lee, J., Torre‐Amione, G., Birdsall, H. H., Ma, T. S., & Mann, D. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118090 · Cited by 437
The Distinct Roles of TRAF2 and RIP in IKK Activation by TNF-R1
Devin, A., Cook, A., Lin, Y., Rodriguez, Y., Kelliher, M. A., & Liu, Z.-G. (2000) · Immunity · doi:10.1016/s1074-7613(00)80194-6 · Cited by 433
Impaired IgA class switching in APRIL-deficient mice
Castigli, E., Scott, S., Dedeoğlu, F., Bryce, P. J., Jabara, H. H., Bhan, A. K., Mizoguchi, E., & Geha, R. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307348101 · Cited by 432
Activation and accumulation of B cells in TACI-deficient mice
Yan, M., Wang, H., Chan, B., Roose-Girma, M., Erickson, S. L., Baker, T., Tumas, D. B., Grewal, I. S., & Dixit, V. M. (2001) · Nature Immunology · doi:10.1038/89790 · Cited by 414
Inflammatory Process in Parkinsons Disease: Role for Cytokines
Nagatsu, T., & Sawada, M. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381620 · Cited by 412
Yan, M., Brady, J. R., Chan, B., Lee, W. P., Hsu, B. L., Harless, S. M., Cancro, M. P., Grewal, I. S., & Dixit, V. M. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00481-x · Cited by 393
Gene defect in ectodermal dysplasia implicates a death domain adapter in development
Headon, D. J., Emmal, S. A., Ferguson, B. M., Tucker, A. S., Justice, M. J., Sharpe, P. T., Zonana, J., & Overbeek, P. A. (2001) · Nature · doi:10.1038/414913a · Cited by 378
Abnormal development of secondary lymphoid tissues in lymphotoxin β-deficient mice
Alimzhanov, M. B., Kuprash, D. V., Kosco‐Vilbois, M. H., Luz, A., Turetskaya, R. L., Tarakhovsky, A., Rajewsky, K., Nedospasov, S. A., & Pfeffer, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9302 · Cited by 370
Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice
Lamhamedi-Cherradi, S.-E., Zheng, S. J., Maguschak, K. A., Peschon, J. J., & Chen, Y. H. (2003) · Nature Immunology · doi:10.1038/ni894 · Cited by 350
de Diego, R. P., Sancho‐Shimizu, V., Lorenzo, L., Puel, A., Plancoulaine, S., Pïcard, C., Casadio, M., Cardon, A., Durandy, A., Bustamante, J. C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.014 · Cited by 348
Tzanavari, T., Giannogonas, P., & Karalis, K. P. (2010) · Current directions in autoimmunity · doi:10.1159/000289203 · Cited by 333
Inhibition of tumor necrosis factor by curcumin, a phytochemical
Chan, M. M.-Y. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00171-u · Cited by 304
Kim, N., Odgren, P. R., Kim, D., Marks, S. C., & Choi, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200294797 · Cited by 299
Role for TNF in atherosclerosis? Lessons from autoimmune disease
McKellar, G., McCarey, D. W., Sattar, N. A., & McInnes, I. B. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.57 · Cited by 299
Knight, B., Yeoh, G. C., Husk, K. L., Ly, T., Abraham, L. J., Yu, C., Rhim, J. A., & Fausto, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1809 · Cited by 299
Aggarwal, B. B., Moffat, B., & Harkins, R. N. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43716-1 · Cited by 290
Self-citationErmolaeva, M., Michallet, M., Papadopoulou, N., Utermöhlen, O., Kranidioti, K., Kollias, G. A., Tschopp, J., & Pasparakis, M. (2008) · Nature Immunology · doi:10.1038/ni.1638 · Cited by 277
Yuasa, T., Ohno, S., Kehrl, J. H., & Kyriakis, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22681 · Cited by 268
Tumor Necrosis Factor–α Overexpression in Lung Disease
Lundblad, L. K. A., Thompson-Figueroa, J. A., Leclair, T. R., Sullivan, M. J., Poynter, M. E., Irvin, C. G., & Bates, J. H. T. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1349oc · Cited by 261
Targeted Disruption of TRAF3 Leads to Postnatal Lethality and Defective T-Dependent Immune Responses
Xu, Y., Cheng, G., & Baltimore, D. (1996) · Immunity · doi:10.1016/s1074-7613(00)80497-5 · Cited by 243
Cundy, T. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.18.2119 · Cited by 228
Schneider, P., Street, S. L., Gaide, O., Hertig, S., Tardivel, A., Tschopp, J., Runkel, L., Alevizopoulos, K., Ferguson, B. M., & Zonana, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101280200 · Cited by 222
Immune Responses in 4-1BB (CD137)-Deficient Mice
Kwon, B. S., Hurtado, J., Lee, Z. H., Kwack, K. B., Seo, S. K., Choi, B. K., Koller, B. H., Wolisi, G. O., Broxmeyer, H. E., & Vinay, D. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5483 · Cited by 221
Girgenrath, M., Weng, S., Kostek, C. A., Browning, B., Wang, M., Brown, S. A. N., Winkles, J. A., Michaelson, J. S., Allaire, N., Schneider, P., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601441 · Cited by 217
Monreal, A. W., Zonana, J., & Ferguson, B. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301984 · Cited by 206
Reactive Oxygen Species in TNFα-Induced Signaling and Cell Death
Morgan, M. J., & Liu, Z.-G. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0105-0 · Cited by 203
Watts, A. D., Hunt, N. H., Wanigasekara, Y., Bloomfield, G., Wallach, D., Roufogalis, B. D., & Chaudhri, G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2119 · Cited by 195
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation
Nakano, H., Komazawa‐Sakon, S., Koseki, H., Takemori, T., Tada, K., Matsumoto, M., Munechika, E., Sakai, T., Shirasawa, T., Akiba, H., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9803 · Cited by 189
TRAF6 -deficient mice display hypohidrotic ectodermal dysplasia
Naito, A., Yoshida, H., Nishioka, E., Satoh, M., Azuma, S., Yamamoto, T. S., Nishikawa, S., & Inoue, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132636999 · Cited by 183
APRIL-Deficient Mice Have Normal Immune System Development
Varfolomeev, E. E., Kischkel, F. C., Martin, F., Seshasayee, D., Wang, H., Lawrence, D. A., Olsson, C., Tom, L., Erickson, S. L., French, D. M., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.997-1006.2004 · Cited by 182
TRAF1 Is a Negative Regulator of TNF Signaling
Tsitsikov, E. N., Laouini, D., Dunn, I. F., Sannikova, T., Davidson, L., Alt, F. W., & Geha, R. S. (2001) · Immunity · doi:10.1016/s1074-7613(01)00207-2 · Cited by 180
Tumor Necrosis Factor–Like Weak Inducer of Apoptosis Is a Mitogen for Liver Progenitor Cells
Tirnitz-Parker, J. E. E., Viebahn, C. S., Jakubowski, A., Klopcic, B. R. S., Olynyk, J. K., Yeoh, G. C. T., & Knight, B. (2010) · Hepatology · doi:10.1002/hep.23663 · Cited by 177
Reverse signaling via CD30 ligand
Wiley, S. R., Goodwin, R. G., & Smith, C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3635 · Cited by 175
Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line.
Aggarwal, B. B., Henzel, W. J., Moffat, B., Kohr, W. J., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89559-x · Cited by 170
Self-citationGaspal, F., Kim, M., McConnell, F. M., Raykundalia, C., Bekiaris, V., & Lane, P. J. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.3891 · Cited by 169
van Vollenhoven, R., Kinnman, N., Vincent, E., Wax, S. D., & Bathon, J. M. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30372 · Cited by 167
TNF-α as a molecular target in bipolar disorder
Brietzke, E., & Kapczinski, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.01.006 · Cited by 163
Sayed, B. A., Christy, A. L., Walker, M. E., & Brown, M. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000126 · Cited by 163
Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation
Schreiber, T. H., Wolf, D., Tsai, M. S., Chirinos, J., Deyev, V. V., Gonzalez, L. E., Malek, T. R., Levy, R. B., & Podack, E. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42933 · Cited by 163
Receptor-Mediated Choreography of Life and Death
Bhardwaj, A., & Aggarwal, B. B. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1025319031417 · Cited by 150
Self-citationNguyen, L. T., Duncan, G. S., Mirtsos, C., Ng, M. S. W., Speiser, D. E., Shahinian, A., Marino, M. W., Mak, T. W., Ohashi, P. S., & Yeh, W. (1999) · Immunity · doi:10.1016/s1074-7613(00)80113-2 · Cited by 139
Magérus, A., Neven, B., Stolzenberg, M., Daussy, C., Arkwright, P. D., Lanzarotti, N., Schaffner, C., Cluet-Dennetiere, S., Haerynck, F., Michel, G., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43752 · Cited by 131
TNF-α inhibitors in asthma and COPD: We must not throw the baby out with the bath water
Matera, M. G., Calzetta, L., & Cazzola, M. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.10.007 · Cited by 130
Schneider, P., Olson, D. L., Tardivel, A., Browning, B., Lugovskoy, A. A., Gong, D., Dobles, M., Hertig, S., Hofmann, K., van Vlijmen, H., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210783200 · Cited by 130
Harashima, S., Horiuchi, T., Hatta, N., Morita, C., Higuchi, M., Sawabe, T., Tsukamoto, H., Tahira, T., Hayashi, K., Fujita, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.130 · Cited by 129
Atacicept: targeting B cells in multiple sclerosis
Hartung, H., & Kieseier, B. C. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610371146 · Cited by 129
Genovese, M. C., Kinnman, N., Bourdonnaye, G. D. L., Rossi, C. P., & Tak, P. P. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30373 · Cited by 123
CD137 (4–1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice
Jeon, H. J., Choi, J., Jung, I., Park, J., Lee, M., Lee, M.-N., Kim, B., Yoo, J. Y., Jeong, S., Kim, D.-Y., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.882704 · Cited by 120
DR3 Regulates Negative Selection during Thymocyte Development
Wang, E. C. Y., Thern, A. M., Denzel, A., Kitson, J., Farrow, S. N., & Owen, M. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3451-3461.2001 · Cited by 115
Tumor Necrosis Factor (TNF) Receptor 1 Signaling Downstream of TNF Receptor-associated Factor 2
Natoli, G., Costanzo, A., Moretti, F., Fulco, M., Balsano, C., & Levrero, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26079 · Cited by 114
DR5 Knockout Mice Are Compromised in Radiation-Induced Apoptosis
Finnberg, N. K., Gruber, J. J., Fei, P., Rudolph, D., Bric, A., Kim, S., Burns, T. F., Ajuha, H., Page, R., Wu, G. S., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.2000-2013.2005 · Cited by 114
Jacobson, B. A., Panka, D. J., Nguyen, K.-A., Erikson, J., Abbas, A. K., & Marshak‐Rothstein, A. (1995) · Immunity · doi:10.1016/1074-7613(95)90179-5 · Cited by 109
The potential role of tumour necrosis factor a in asthma
KIPS, J. C., Tavernier, J. H., Joos, G. F., Peleman, R. A., & Pauwels, R. (1993) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1993.tb00317.x · Cited by 108
Deroose, J. P., Eggermont, A. M. M., van Geel, A. N., Burger, J. W. A., den Bakker, M. A., de Wilt, J. H. W., & Verhoef, C. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6618 · Cited by 104
Inflammatory Mediators and the Failing Heart: A Translational Approach
Diwan, A., Tran, T. T., Misra, A., & Mann, D. L. (2003) · Current Molecular Medicine · doi:10.2174/1566524033361537 · Cited by 93
Vinay, D. S., Choi, B. K., Bae, J. S., Kim, W. Y., Gebhardt, B. M., & Kwon, B. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4218 · Cited by 91
Kelker, H. C., Oppenheim, J. D., Stone‐Wolff, D. S., Henriksen-DeStefano, D., Aggarwal, B. B., Stevenson, H. C., & Vilček, J. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910360112 · Cited by 88
Self-citationLee, S., Park, Y., So, T., Kwon, B. S., Cheroutre, H., Mittler, R. S., & Croft, M. (2008) · Nature Immunology · doi:10.1038/ni.1632 · Cited by 86
Enhanced CD4+ T Cell Proliferation and Th2 Cytokine Production in DR6-Deficient Mice
Liu, J., Na, S., Glasebrook, A. L., Fox, N. W., Solenberg, P. J., Zhang, Q., Song, H. Y., & Yang, D. D. (2001) · Immunity · doi:10.1016/s1074-7613(01)00162-5 · Cited by 83
Regulation of TRAIL-Induced Apoptosis by Ectopic Expression of Antiapoptotic Factors
Aggarwal, B. B., Bhardwaj, U., & Takada, Y. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)67023-3 · Cited by 77
Self-citationMyodegeneration in EDA-A2 Transgenic Mice Is Prevented by XEDAR Deficiency
Newton, K., French, D. M., Yan, M., Frantz, G. D., & Dixit, V. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1608-1613.2004 · Cited by 76
Deroose, J. P., Eggermont, A. M. M., van Geel, A. N., de Wilt, J. H. W., Burger, J. W. A., & Verhoef, C. K. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2030-7 · Cited by 75
Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN‐deficient mice
Kreder, D. E., Krut, O., Adam‐Klages, S., Wiegmann, K., Scherer, G., Plitz, T., Jensen, J., Proksch, E., Steinmann, J., Pfeffer, K., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2472 · Cited by 75
O'Malley, W. E., Achinstein, B., & Shear, M. J. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1988.tb05376.x · Cited by 73
Pispa, J., Pummila, M., Barker, P. A., Thesleff, I., & Mikkola, M. L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn232 · Cited by 71
Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling
Li, X. (2007) · Cytokine · doi:10.1016/j.cyto.2007.09.015 · Cited by 70
Missiou, A., Köstlin, N., Varo, N., Rudolf, P., Aichele, P., Ernst, S., Münkel, C., Walter, C., Stachon, P., Sommer, B., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.895037 · Cited by 69
Waschke, K. A., Villani, A., Vermeire, S., Dufresne, L., Chen, T.-C., Bitton, A., Cohen, A., Thomson, A. B. R., & Wild, G. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40534.x · Cited by 67
Fas Engagement Increases Expression of Interleukin-6 in Human Glioma Cells
Choi, C., Gillespie, G. Y., Wagoner, N. J. V., & Benveniste, E. N. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1014467626314 · Cited by 64
Bringman, T. S., & Aggarwal, B. B. (1987) · Hybridoma · doi:10.1089/hyb.1987.6.489 · Cited by 61
Self-citationZhao, H., Yan, M., Wang, H., Erickson, S. L., Grewal, I. S., & Dixit, V. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1441 · Cited by 60
Collison, A., Foster, P. S., & Mattes, J. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05258.x · Cited by 56
Mutation identification in a canine model of X-linked ectodermal dysplasia
Casal, M. L., Scheidt, J. L., Rhodes, J. L., Henthorn, P. S., & Werner, P. (2005) · Mammalian Genome · doi:10.1007/s00335-004-2463-4 · Cited by 55
Signal Transduction by Tumor Necrosis Factor
Goeddel, D. V. (1999) · CHEST Journal · doi:10.1378/chest.116.suppl_1.69s · Cited by 52
Enhanced B Cell Expansion, Survival, and Humoral Responses by Targeting Death Receptor 6
Schmidt, C. S., Liu, J., Zhang, T., Song, H. Y., Sandusky, G. E., Mintze, K., Benschop, R. J., Glasebrook, A. L., Yang, D. D., & Na, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020617 · Cited by 51
TNF-α and TNF-β Gene Polymorphisms in Cerebral Infarction
Um, J., An, N.-H., & Kim, H. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:21:2:167 · Cited by 50
Ida, H. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh320 · Cited by 46
Boyce, E. G., Halilovic, J., & Stan-Ugbene, O. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.09.003 · Cited by 43
Shimomura, Y., Sato, N., Miyashita, A., Hashimoto, T., Ito, M., & Kuwano, R. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23405.x · Cited by 43
Middleton-Hardie, C., Zhu, Q., Cundy, H., Lin, J.-M., Callon, K., Tong, P. C., Xu, J., Grey, A., Cornish, J., & Naot, D. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051104 · Cited by 41
The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases
Vinay, D. S., & Kwon, B. S. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04375.x · Cited by 35
Grünhagen, D. J., de Wilt, J. H. W., van Geel, A. N., Verhoef, C. K., & Eggermont, A. M. M. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-77960-5_16 · Cited by 31
The value of failure: the discovery of TNF and its natural inhibitor erythropoietin
Cerami, A. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02319.x · Cited by 23
Tumor necrosis factor-alpha exhibits greater proinflammatory activity than lymphotoxin in vitro
Desch, C. E., Dobrina, A., Aggarwal, B. B., & Harlan, J. (1990) · Blood · doi:10.1182/blood.v75.10.2030.2030 · Cited by 22
Self-citationTWEAK regulates proliferation and differentiation of adult neural progenitor cells
Schölzke, M. N., Röttinger, A., Murikinati, S. R., Gehrig, N., Leib, C., & Schwaninger, M. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.10.004 · Cited by 22
Systemic autoimmunity in BAFF‐R‐mutant A/WySnJ strain mice
Mayne, C. G., Amanna, I. J., Nashold, F. E., & Hayes, C. E. (2008) · European Journal of Immunology · doi:10.1002/eji.200737817 · Cited by 22
TRAIL-Deficient Mice Exhibit Delayed Regression of Retinal Neovascularization
Hubert, K. E., Davies, M. H., Stempel, A. J., Griffith, T. S., & Powers, M. R. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090099 · Cited by 18
Murashima, Y., Suzuki, J., & Yoshii, M. (2008) · Gene Regulation and Systems Biology · doi:10.1177/117762500800200004 · Cited by 18
Research works printed but not linked: 1
- Wua, 2010, Docking prediction for tumor necrosis factor-α and five herbal inhibitors., Intl J Eng Sci Technol, 2, 4263
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Jang, D.-I., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T., Lee, S., & Yang, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052719 · Cited by 1,864
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
Kalliolias, G. D., & Ivashkiv, L. B. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.169 · Cited by 1,453
Regulation of NF-κB by TNF family cytokines
Hayden, M. S., & Ghosh, S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.05.004 · Cited by 1,167
Chemical Biology of H 2 S Signaling through Persulfidation
Filipović, M. R., Živanović, J., Álvarez, B., & Banerjee, R. V. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00205 · Cited by 1,059
Metadata
- Authors
- Aggarwal, B. B., Gupta, S. C., & Kim, J. H.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2012-01-19
- Volume
- 119
- Issue
- 3
- Pages
- 651-665
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC3265196
- OpenAlex
- W1989219560
- Cited by
- 877
- References
- 144
- Citations by year
- 2026: 35 · 2025: 76 · 2024: 72 · 2023: 82 · 2022: 57 · 2021: 74 · 2020: 76 · 2019: 62 · 2018: 45 · 2017: 59 · 2016: 62 · 2015: 70 · 2014: 49 · 2013: 41 · 2012: 13
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA-16 672, 16672, CA-124787-01A2)
- Genentech
- University of California, San Francisco
- National Cancer Institute (CA-16672, P01CA124787, CA-124787-01A2, P30CA016672)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- TNF-α, TNF superfamily, lymphotoxin, TNF receptor, TNF-alpha inhibitors, apoptosis, inflammation, angiogenesis, metastasis, drug development, rheumatoid arthritis, psoriasis, Crohn's disease, osteoporosis
- MeSH terms
- Humans, Neoplasms, Tumor Necrosis Factor-alpha, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review